Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis (Q38341003)

2 September 2017

Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis (English)

1 reference

2 September 2017

1 reference

3

Robin Farias-Eisner

1 reference

2 September 2017

Pouya Pakneshan

1

1 reference

2 September 2017

Moshe Szyf

series ordinal

2

1 reference

2 September 2017

Shafaat A Rabbani

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

18 May 2004

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

279

1 reference

2 September 2017

30

1 reference

2 September 2017

31735-31744

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: a review

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Methionine metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Gene silencing by S-adenosylmethionine in muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Diet and DNA Methylation Interactions in Cancer Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Antisense MBD2 gene therapy inhibits tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Deficiency of Mbd2 suppresses intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Suppression of intestinal neoplasia by DNA hypomethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Towards a pharmacology of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Targeting DNA methylation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

DNA methyltransferase inhibitors-state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

DNA methylation in cancer: too much, but also too little

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Induction of Tumors in Mice by Genomic Hypomethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

cis modification of the steroid 21-hydroxylase gene prevents its expression in the Y1 mouse adrenocortical tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

CpG methylation, chromatin structure and gene silencing-a three-way connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401669200

21 January 2018

Identifiers

DOI

10.1074/JBC.M401669200

1 reference

2 September 2017

1 reference